Every story and comment from the Hacker News API, in a layout borrowed from 2001.
A comment on When Dying Patients Want Unproven Drugs. Parent comment
BioNTech has a similar treatment that's also been apparently slow to launch Phase III trials.
There are no comments on this comment yet.
BioNTech has a similar treatment that's also been apparently slow to launch Phase III trials.